These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22329947)

  • 21. Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale.
    Talepoor AG; Fouladseresht H; Khosropanah S; Doroudchi M
    Endocr Metab Immune Disord Drug Targets; 2020; 20(4):525-545. PubMed ID: 31622224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.
    Upadhye A; Sturek JM; McNamara CA
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):309-322. PubMed ID: 31852222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead.
    Sun L; Zhang W; Zhao Y; Wang F; Liu S; Liu L; Zhao L; Lu W; Li M; Xu Y
    Front Immunol; 2020; 11():1456. PubMed ID: 32849502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell-associated MAVS is required to control West Nile virus replication and ensuing humoral immune responses.
    Roe K; Giordano D; Young LB; Draves KE; Holder U; Suthar MS; Gale M; Clark EA
    PLoS One; 2019; 14(6):e0218928. PubMed ID: 31242236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
    Mrak D; Tobudic S; Koblischke M; Graninger M; Radner H; Sieghart D; Hofer P; Perkmann T; Haslacher H; Thalhammer R; Winkler S; Blüml S; Stiasny K; Aberle JH; Smolen JS; Heinz LX; Aletaha D; Bonelli M
    Ann Rheum Dis; 2021 Oct; 80(10):1345-1350. PubMed ID: 34285048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral innate immune response and disease.
    Shishido SN; Varahan S; Yuan K; Li X; Fleming SD
    Clin Immunol; 2012 Aug; 144(2):142-58. PubMed ID: 22771788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type-I interferons in atherosclerosis.
    Chen HJ; Tas SW; de Winther MPJ
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31821440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease.
    O'Brien JW; Case A; Kemper C; Zhao TX; Mallat Z
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1512-1522. PubMed ID: 38813699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension: An immune related disorder?
    Sereti E; Stamatelopoulos KS; Zakopoulos NA; Evangelopoulou A; Mavragani CP; Evangelopoulos ME
    Clin Immunol; 2020 Mar; 212():108247. PubMed ID: 31401215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.
    Sage AP; Mallat Z
    Br J Pharmacol; 2017 Nov; 174(22):3926-3939. PubMed ID: 28052311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atherosclerosis: the interplay between lipids and immune cells.
    Schaftenaar F; Frodermann V; Kuiper J; Lutgens E
    Curr Opin Lipidol; 2016 Jun; 27(3):209-15. PubMed ID: 27031276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis.
    Chen L; Ishigami T; Doi H; Arakawa K; Tamura K
    J Mol Med (Berl); 2020 Sep; 98(9):1235-1244. PubMed ID: 32737524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cells interactions in lipid immune responses: implications in atherosclerotic disease.
    Echeverri Tirado LC; Yassin LM
    Lipids Health Dis; 2017 Feb; 16(1):30. PubMed ID: 28166809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.
    Centa M; Jin H; Hofste L; Hellberg S; Busch A; Baumgartner R; Verzaal NJ; Lind Enoksson S; Perisic Matic L; Boddul SV; Atzler D; Li DY; Sun C; Hansson GK; Ketelhuth DFJ; Hedin U; Wermeling F; Lutgens E; Binder CJ; Maegdesfessel L; Malin SG
    Circulation; 2019 May; 139(21):2466-2482. PubMed ID: 30894016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptive T cell immune responses and atherogenesis.
    Taleb S; Tedgui A; Mallat Z
    Curr Opin Pharmacol; 2010 Apr; 10(2):197-202. PubMed ID: 20207195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.
    Lee AYS; Körner H
    Immunobiology; 2019 May; 224(3):449-454. PubMed ID: 30772094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plan B (-cell) in atherosclerosis.
    Nus M; Tsiantoulas D; Mallat Z
    Eur J Pharmacol; 2017 Dec; 816():76-81. PubMed ID: 28882560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shaping the humoral immune response: Actin regulators modulate antigen presentation and influence B-T interactions.
    Burbage M; Keppler SJ
    Mol Immunol; 2018 Sep; 101():370-376. PubMed ID: 30055407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of immune cells in different stages of atherosclerosis.
    He C; Kim HI; Park J; Guo J; Huang W
    Int J Med Sci; 2024; 21(6):1129-1143. PubMed ID: 38774746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.
    Milioti N; Bermudez-Fajardo A; Penichet ML; Oviedo-Orta E
    Clin Dev Immunol; 2008; 2008():723539. PubMed ID: 18551190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.